Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association

DM Ferriero, HJ Fullerton, TJ Bernard, L Billinghurst… - Stroke, 2019 - Am Heart Assoc
Purpose—Much has transpired since the last scientific statement on pediatric stroke was
published 10 years ago. Although stroke has long been recognized as an adult health …

Multiorgan involvement and management in children with Down syndrome

N Lagan, D Huggard, F Mc Grane, TR Leahy… - Acta …, 2020 - Wiley Online Library
Aim To review multiorgan involvement and management in children with Down syndrome
(DS). Methods A literature review of articles from 1980 to 2019 using the MEDLINE interface …

Health supervision for children and adolescents with Down syndrome

MJ Bull, T Trotter, SL Santoro, C Christensen… - …, 2022 - publications.aap.org
This clinical report is designed to assist the pediatrician in caring for the child, adolescent,
and family in whom a diagnosis of Down syndrome has been confirmed by chromosome …

Neurologic complications of Down syndrome: a systematic review

JD Santoro, D Pagarkar, DT Chu, M Rosso… - Journal of …, 2021 - Springer
Down syndrome (DS) is one of the most well-recognized genetic disorders. Persons with DS
are known to have a variety of co-morbid medical problems, affecting nearly all organ …

Surgical outcomes for pediatric moyamoya: a systematic review and meta-analysis

K Ravindran, JC Wellons, MC Dewan - Journal of Neurosurgery …, 2019 - thejns.org
OBJECTIVE The optimal revascularization for pediatric moyamoya for reducing the
incidence of future stroke events remains to be determined. METHODS The authors …

Clinical presentation and stroke incidence differ by moyamoya etiology

JR Gatti, AG Torriente, LR Sun - Journal of child neurology, 2021 - journals.sagepub.com
Introduction: Moyamoya arteriopathy, which can be idiopathic or associated with sickle cell
disease, neurofibromatosis, Down syndrome, or cranial radiation therapy, is a progressive …

Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres

J Feghali, R Xu, W Yang, JA Liew, J Blakeley… - Journal of …, 2019 - thejns.org
OBJECTIVE Phenotypic differences between moyamoya disease (MMD) and moyamoya
syndrome (MMS) remain unclear. The purpose of this study was to evaluate whether such …

Increased autoimmunity in individuals with Down syndrome and moyamoya disease

JD Santoro, S Lee, AC Wang, E Ho, D Nagesh… - Frontiers in …, 2021 - frontiersin.org
Objective: To determine if elevated rates of autoimmune disease are present in children with
both Down syndrome and moyamoya disease given the high rates of autoimmune disease …

[HTML][HTML] Cardiovascular physiology and pathophysiology in Down syndrome

BT Cilhoroz, CN Receno, KS Heffernan… - Physiological …, 2022 - ncbi.nlm.nih.gov
Summary Down Syndrome (Ds) is the most common chromosomal cause of intellectual
disability that results from triplication of chromosome 21 genes. Individuals with Ds …

[HTML][HTML] Western moyamoya phenotype: a scoping review

R Miller, SR Unda, R Holland, DJ Altschul - Cureus, 2021 - ncbi.nlm.nih.gov
Moyamoya, a rare angiographic finding, is characterized by chronic and progressive
stenosis at the terminal end of the internal carotid artery, followed by collateralization of the …